These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8864475)

  • 1. Somatostatin 1-12 immunoreactivity is decreased in the hypothalamic lateral tuberal nucleus of Huntington's disease patients.
    Timmers HJ; Swaab DF; van de Nes JA; Kremer HP
    Brain Res; 1996 Jul; 728(2):141-8. PubMed ID: 8864475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypothalamic lateral tuberal nucleus: normal anatomy and changes in neurological diseases.
    Kremer HP
    Prog Brain Res; 1992; 93():249-61. PubMed ID: 1362279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrophy of the hypothalamic lateral tuberal nucleus in Huntington's disease.
    Kremer HP; Roos RA; Dingjan G; Marani E; Bots GT
    J Neuropathol Exp Neurol; 1990 Jul; 49(4):371-82. PubMed ID: 2141871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hypothalamic lateral tuberal nucleus and the characteristics of neuronal loss in Huntington's disease.
    Kremer HP; Roos RA; Dingjan GM; Bots GT; Bruyn GW; Hofman MA
    Neurosci Lett; 1991 Oct; 132(1):101-4. PubMed ID: 1838577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia.
    Albin RL; Reiner A; Anderson KD; Penney JB; Young AB
    Ann Neurol; 1990 Apr; 27(4):357-65. PubMed ID: 1972318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Huntington's disease is accompanied by changes in the distribution of somatostatin-containing neuronal processes.
    Marshall PE; Landis DM
    Brain Res; 1985 Mar; 329(1-2):71-82. PubMed ID: 2858256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-protein/A4 deposits are not associated with hyperphosphorylated tau in somatostatin neurons in the hypothalamus of Alzheimer's disease patients.
    van de Nes JA; Konermann S; Nafe R; Swaab DF
    Acta Neuropathol; 2006 Feb; 111(2):126-38. PubMed ID: 16456666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease.
    Dawbarn D; De Quidt ME; Emson PC
    Brain Res; 1985 Aug; 340(2):251-60. PubMed ID: 2862959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington's disease.
    Beal MF; Mazurek MF; Ellison DW; Swartz KJ; McGarvey U; Bird ED; Martin JB
    Ann Neurol; 1988 Jun; 23(6):562-9. PubMed ID: 2900622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid and neuropeptide neurotransmitters in Huntington's disease cerebellum.
    Beal MF; Swartz KJ; Finn SF; Bird ED; Martin JB
    Brain Res; 1988 Jun; 454(1-2):393-6. PubMed ID: 2457409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical distribution of somatostatin in the infant hypothalamus.
    Najimi M; Chigr F; Leduque P; Jordan D; Charnay Y; Chayvialle JA; Tohyama M; Kopp N
    Brain Res; 1989 Apr; 483(2):205-20. PubMed ID: 2565149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lewy bodies in the lateral hypothalamus: do they imply neuronal loss?
    Kremer HP; Bots GT
    Mov Disord; 1993 Jul; 8(3):315-20. PubMed ID: 8341295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colocalization of somatostatin receptor subtypes (SSTR1-5) with somatostatin, NADPH-diaphorase (NADPH-d), and tyrosine hydroxylase in the rat hypothalamus.
    Kumar U
    J Comp Neurol; 2007 Sep; 504(2):185-205. PubMed ID: 17626271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic alterations in Huntington's disease patients: comparison with genetic rodent models.
    van Wamelen DJ; Aziz NA; Roos RA; Swaab DF
    J Neuroendocrinol; 2014 Nov; 26(11):761-75. PubMed ID: 25074766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced density of striatal somatostatin receptors in Huntington's chorea.
    Palacios JM; Rigo M; Chinaglia G; Probst A
    Brain Res; 1990 Jul; 522(2):342-6. PubMed ID: 1977497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease.
    Ferrante RJ; Kowall NW; Beal MF; Martin JB; Bird ED; Richardson EP
    J Neuropathol Exp Neurol; 1987 Jan; 46(1):12-27. PubMed ID: 2947977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression pattern of apoptosis-related markers in Huntington's disease.
    Vis JC; Schipper E; de Boer-van Huizen RT; Verbeek MM; de Waal RM; Wesseling P; ten Donkelaar HJ; Kremer B
    Acta Neuropathol; 2005 Mar; 109(3):321-8. PubMed ID: 15668790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses.
    Gabery S; Murphy K; Schultz K; Loy CT; McCusker E; Kirik D; Halliday G; Petersén A
    Acta Neuropathol; 2010 Dec; 120(6):777-88. PubMed ID: 20821223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Hypothalamic Pathology for Non-Motor Features of Huntington's Disease.
    Cheong RY; Gabery S; Petersén Å
    J Huntingtons Dis; 2019; 8(4):375-391. PubMed ID: 31594240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMPA and NMDA binding sites in the hypothalamic lateral tuberal nucleus: implications for Huntington's disease.
    Kremer B; Tallaksen-Greene SJ; Albin RL
    Neurology; 1993 Aug; 43(8):1593-5. PubMed ID: 7688883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.